Leukemia News

Researchers identify proteins fueling rare childhood leukemia, revealing new treatment strategy - Medical Xpress

Researchers identify proteins fueling rare childhood leukemia, revealing new treatment strategy Medical Xpress

Naveen Pemmaraju: Final Day of Fellowship for 2 Outstanding Leukemia Fellows - Oncodaily

Naveen Pemmaraju: Final Day of Fellowship for 2 Outstanding Leukemia Fellows Oncodaily

College World Series Young leukemia survivor headed to Omaha to cheer on UNC in CWS finals - ABC11 News

College World Series Young leukemia survivor headed to Omaha to cheer on UNC in CWS finals ABC11 News

How surviving leukemia changed Duke Health CEO's approach to patient care - WRAL

How surviving leukemia changed Duke Health CEO's approach to patient care WRAL

Iowa boy with leukemia returns to baseball after parents create shirt to protect chemo port - KCCI

Iowa boy with leukemia returns to baseball after parents create shirt to protect chemo port KCCI

Oncology On The Go: Frontline Chronic Myeloid Leukemia in Chronic Phase: Optimizing Treatment Selection and Molecular Response - CancerNetwork

Oncology On The Go: Frontline Chronic Myeloid Leukemia in Chronic Phase: Optimizing Treatment Selection and Molecular Response CancerNetwork

UT MD Anderson Shares Latest Research Breakthroughs | Newswise - Newswise

UT MD Anderson Shares Latest Research Breakthroughs | Newswise Newswise

Chronic Myeloid Leukemia (CML): Background, Pathophysiology, Epidemiology - Medscape eMedicine

Chronic Myeloid Leukemia (CML): Background, Pathophysiology, Epidemiology Medscape eMedicine

Acute Myeloid Leukemia Therapeutics Market to Exceed USD 10.1 Billion by 2036 as Precision Oncology and Targeted Therapies Transform AML Treatment Landscape: Fact.MR - 24-7 Press Release Newswire

Acute Myeloid Leukemia Therapeutics Market to Exceed USD 10.1 Billion by 2036 as Precision Oncology and Targeted Therapies Transform AML Treatment Landscape: Fact.MR 24-7 Press Release Newswire

Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets - Nature

Integrated proteogenomic and metabolomic profiling of acute myeloid leukemias to identify molecular subtypes and associated therapy targets Nature

Ivosidenib Plus Azacitidine May Be Effective in IDH1 -Mutated AML - Hematology Advisor

Ivosidenib Plus Azacitidine May Be Effective in IDH1 -Mutated AML Hematology Advisor

Richmond dad learned from AI his son had leukemia. Now the family’s helping others touched by childhood cancer - Shaw Local

Richmond dad learned from AI his son had leukemia. Now the family’s helping others touched by childhood cancer Shaw Local

Enliven Therapeutics' leukemia drug shows promise in new study | STAT - statnews.com

Enliven Therapeutics' leukemia drug shows promise in new study | STAT statnews.com

Real-World Treatment Patterns With First-Line BTK Inhibitors in CLL - OncLive

Real-World Treatment Patterns With First-Line BTK Inhibitors in CLL OncLive

Peptide shields DNA from cancer therapy–linked leukemia risk - Wiley Analytical Science

Peptide shields DNA from cancer therapy–linked leukemia risk Wiley Analytical Science

Sonrotoclax Plus Zanubrutinib Achieves Undetectable MRD Rates Above 90% in Frontline CLL/SLL - Pharmacy Times

Sonrotoclax Plus Zanubrutinib Achieves Undetectable MRD Rates Above 90% in Frontline CLL/SLL Pharmacy Times

Iowa boy with leukemia returns to baseball after parents create shirt to protect chemo port - Yahoo News Canada

Iowa boy with leukemia returns to baseball after parents create shirt to protect chemo port Yahoo News Canada

Fixed-Duration Triplet Therapy Demonstrates Efficacy for Patients with Relapsed/Refractory CLL - Cancer Health

Fixed-Duration Triplet Therapy Demonstrates Efficacy for Patients with Relapsed/Refractory CLL Cancer Health

Acute Myeloid Leukemia (AML): Background, Pathophysiology, Etiology - Medscape eMedicine

Acute Myeloid Leukemia (AML): Background, Pathophysiology, Etiology Medscape eMedicine

Inhibiting high levels of leukemia ABCD1 protein with jojoba could lead to new treatment option - Medical Xpress

Inhibiting high levels of leukemia ABCD1 protein with jojoba could lead to new treatment option Medical Xpress

Dr Cuglievan on Results for Revumenib in Pediatric R/R KMT2A+ Acute Leukemia - OncLive

Dr Cuglievan on Results for Revumenib in Pediatric R/R KMT2A+ Acute Leukemia OncLive

Leading the Charge in Acute Myeloid Leukemia - CU Anschutz newsroom

Leading the Charge in Acute Myeloid Leukemia CU Anschutz newsroom

Targeted degradation of CBP/p300 by CBPD-409 exhibits robust anti-myeloma activity - Nature

Targeted degradation of CBP/p300 by CBPD-409 exhibits robust anti-myeloma activity Nature

Gilteritinib Yields Comparable Efficacy vs Midostaurin in Newly Diagnosed FLT3-Mutated AML but Fails to Meet Phase 3 Primary End Point - OncLive

Gilteritinib Yields Comparable Efficacy vs Midostaurin in Newly Diagnosed FLT3-Mutated AML but Fails to Meet Phase 3 Primary End Point OncLive

Postdoc Portrait: Tarang Gaur Studies Drug Resistance in Leukemia - the-scientist.com

Postdoc Portrait: Tarang Gaur Studies Drug Resistance in Leukemia the-scientist.com

A novel class of personalized cancer medicines for hematologic malignancies - Open Access Government

A novel class of personalized cancer medicines for hematologic malignancies Open Access Government

Enliven Therapeutics (ELVN) Soars on Stellar Leukemia Drug Trial - Yahoo Finance

Enliven Therapeutics (ELVN) Soars on Stellar Leukemia Drug Trial Yahoo Finance

YOUR PET'S HEALTH: What is feline leukemia? - Finger Lakes Times

YOUR PET'S HEALTH: What is feline leukemia? Finger Lakes Times

After a long childhood cancer journey, this family is embracing life and dancing - CBS News

After a long childhood cancer journey, this family is embracing life and dancing CBS News

Leukemia: What Primary Care Physicians Need to Know - American Academy of Family Physicians | AAFP

Leukemia: What Primary Care Physicians Need to Know American Academy of Family Physicians | AAFP

Mechanisms controlling gene expression offer avenues for leukemia treatment and diagnosis - St. Jude Children's Research Hospital

Mechanisms controlling gene expression offer avenues for leukemia treatment and diagnosis St. Jude Children's Research Hospital